Diagnosis and management of Skin and Soft-Tissue Infections (SSTI): a Literature Review and Consensus Statement on Behalf of the Italian Society of Infectious Diseases and International Society of Chemotherapy

REFERENCES

• DiNubile MJ, Lipsky BA. Complicated infections of skin and skin struc-tures: when the infection is more than skin deep. J Antimicrob Chemother 2004; 53 (suppl 2): 37-50.
   Google Scholar
• Nichols RL, Florman S. Clinical presentations of soft-tissue infections and surgical site infections. Clin Infect Dis 2001; 33 (suppl 2): S84-93.
   Google Scholar
• Eron LI, Lipsky BA, Low DE, Nathwani D, Tice AD, Volturo GA. Ex-pert panel on managing skin and soft tissue infections. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother. 2003; 52 Suppl 1: 3–17.
   Google Scholar
• Wilson SE, Solomkin JS, Vu Le MS et al. Am J Surg 2003; 185: 369–375.
   PubMed Web of Science ®Google Scholar
• Ki V, Rotstein C. Can J Infect Dis Med Micro 2008; 19 (2): 173-184.
   Google Scholar
• Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Gold-stein EJ, et al. Infectious Diseases Society of America. Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections. Clin Infect Dis. 2005; 41 (10): 1373–406.
   PubMed Web of Science ®Google Scholar
• www.cdc.gov/ncidod/dhqp/healthdis.html, 2009.
   Google Scholar
• Fung FIB, Chang JY, Kuczynski S. A Practical Guide to the Treatment of Complicated Skin and Soft Tissue Infections. Drugs 2003; 63 (14): 1459–80.
   PubMed Web of Science ®Google Scholar
• Leese G., Nathwani D., Young M. et al. Use of antibiotics in people with diabetic foot disease: A consensus statement. Diab Foot 2009; 12: 62–78
   Google Scholar
• Kish MA. Guide to development of practice guidelines. Clin Infect Dis. 2001; 32 (6): 851–4.
   PubMed Web of Science ®Google Scholar
• Bowler PG, Duerden BI, Amstrong DG. Wound microbiology and as-sociated approaches to wound management. Clin Microbiol Rev. 2001; 14 (2): 244–69.
   PubMed Web of Science ®Google Scholar
• Papasian CJ, Kragel PJ. The microbiology laboratoryis role in life-threatening infections. Crit Care Nurs Q. 1997; 20 (3): 44–59.
   PubMedGoogle Scholar
• Neil JA, Munro CL. A comparison of two culturing methods for chronic wounds. Ostomy Wound Manag. 1997; 43: 20–30.
   PubMedGoogle Scholar
• Armstrong DG, Liswood PJ, Todd WF. 1995 William J. Stickel Bronze Award. Prevalence of mixed infections in the diabetic pedal wound. A retrospective review of 112 infections. J Am Podiatr Med Assoc. 1995 Oct;85 (10): 533-7.
   Google Scholar
• Sapico FL, Witte JL, CanawatiMontgomerie JZ, Bessman AN. The infected foot of the diabetic patient: quantitative microbiology and analy-sis of clinical features. Rev Infect Dis. 1984 Mar-Apr;6 Suppl 1: S171-6.
   Google Scholar
• Bouza E, Burillo A, Munoz P, Cercenado E, RodrIguez-CrEixems M. Semiquantitative culture of open surgical wounds for diagnosis of surgical site infection Eur J Clin Microbiol Infect Dis. 2004 Feb; 23 (2): 119–22. .
   Google Scholar
• Bornside GH, Bomside BB. Comparison between moist swab and tis-sue biopsy methods for quantitation of bacteria in experimental incisional wounds. J Trauma 1979; 19: 103–5.
   PubMedGoogle Scholar
• Levine NS, Lindberg RB, Mason AD, Pruitt BA. The quantitative swab culture and smear: a quick simple method for determining the number of vi-able bacteria on open wounds. J. Trauma 1976; 16: 89–94.
   PubMedGoogle Scholar
• Vindenes H, Bjerknes R. Microbial colonisation of large wounds. Burns 1995; 21: 575–9.
   PubMed Web of Science ®Google Scholar
• May AK. Skin and Soft Tissue Infections. Surg Clin North Am. 2009; 89 ( 2): 403-20, viii.
   Google Scholar
• Elliott DC, Kufera JA, Myers RA. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg 1996; 224 (5): 672–83.
   Google Scholar
• McHenry CR, Piotrowski JJ, Petrinic D, Malangoni MA. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg 1995; 221 (5): 558–63.
   PubMed Web of Science ®Google Scholar
• Mossa-Basha M., van Holsbeeck M. Musculoskeletal Infection. Ultra-sound Clin 2. 2007; 2 (4): 639–53.
   Google Scholar
• Arslan A, Pierre-Jerome C, Borthne A. Necrotizing fasciitis: unreliable MRI findings in the preoperative diagnosis. Eur J Radiol. 2000; 36 (3): 139–43.
   PubMed Web of Science ®Google Scholar
• Brothers TE, Tagge DU, Stutley JE, Conway WF, Del Schutte H Jr, Byrne TK. Magnetic resonance imaging differentiates between necrotizing and non-necrotizing fasciitis of the lower extremity. J Am Coll Surg 1998; 187: 416–21.
   Google Scholar
• Jewesson PJ. Pharmaceutical, pharmacokinetic and other considera-tions for intravenous to oral stepdown therapy. Can J Infect Dis. 1995; 6: 11A-6A.
   Google Scholar
• Ferrieri P, Dajani AS, Wannamaker LW, Chapman SS.Natural his-tory of impetigo. I. Site sequence of acquisition and familial patterns of spread of cutaneous streptococci. J Clin Invest. 1972; 51 (11): 2851–62.
   Google Scholar
• Hochedez P, Canestri A, Lecso M, Valin N, Bricaire F, Caumes E. Skin and soft tissue infections in returning travelers. Am J Trop Med Hyg. 2009; 80 (3): 431–4.
   PubMed Web of Science ®Google Scholar
• Moran GJ, Amii RN, Abrahamian FM, Talan DA. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis. 2005; 11 (6): 928–30.
   PubMed Web of Science ®Google Scholar
• Hayward A, Knott F, Petersen I, Livermore DM, Duckworth G, Islam A, Johnson AM. Increasing hospitalizations and general practice prescrip-tions for community-onset staphylococcal disease, England. Emerg Infect Dis. 2008; 14 (5): 720–6.
   PubMed Web of Science ®Google Scholar
• Nathwani D, Morgan M, Masterton RG, Dryden M, Cookson BD, French G, et al. British Society for Antimicrobial Chemotherapy Working Party on Community-onset MRSA Infections. Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus au-reus (MRSA) infections presenting in the community. J Antimicrob Chemother. 2008; 61 (5): 976–94.
   Google Scholar
• Durupt F, Mayor L, Bes M, Reverdy ME, Vandenesch F, Thomas L, et al. Prevalence of Staphylococcus aureus toxins and nasal carriage in fu-runcles and impetigo. Br J Dermatol. 2007; 157 (6): 1161–7.
   PubMed Web of Science ®Google Scholar
• Bernard P, Jarlier V, Santerre-Henriksen A. Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections. Ann Dermatol Venereol. 2008; 135 (1): 13–9.
   PubMed Web of Science ®Google Scholar
• Yamasaki O, Tristan A, Yamaguchi T, Sugai M, Lina G, Bes M, etal. Distribution of the exfoliative toxin D gene in clinical Staphylococcus aureus isolates in France. Clin Microbiol Infect. 2006; 12 (6): 585–8.
   PubMed Web of Science ®Google Scholar
• Darmstadt GL, Lane AT. Impetigo: an overview. Pediatr Dermatol. 1994; 11 (4): 293–303.
   PubMed Web of Science ®Google Scholar
• Sladden MJ, Johnston GA. Common skin infections in children. BMJ. 2004; 329 (7457): 95–9.
   PubMedGoogle Scholar
• Taira BR, Singer AJ, Thode HC Jr, Lee CC. National epidemiology of cutaneous abscesses: 1996 to 2005. Am J Emerg Med. 2009; 27: 289–92.
   PubMed Web of Science ®Google Scholar
• Brook I, Frazier EH. Aerobic and anaerobic bacteriology of wounds and cutaneous abscesses. Arch Surg 1990; 125: 1445–51.
   PubMedGoogle Scholar
• Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, et al. EMERGEncy ID Net Study Group. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355: 666–74.
   Google Scholar
• Baggett HC, Hennessy TW, Rudolph K, Bruden D, Reasonover A, Parkinson A, et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and cytotoxin Panton-Valentine leuko-cidin during a furunculosis outbreak in rural Alaska. J Infect Dis 2004; 189: 1565–73.
   PubMed Web of Science ®Google Scholar
• Wiese-Posselt M, Heuck D, Draeger A, Mielke M, Witte W, Ammon A, et al. Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005. Clin Infect Dis. 2007; 44 (11): e88–95.
   PubMed Web of Science ®Google Scholar
• Chartier C, Grosshans E. Erysipelas: an update. Int J Dermatol 1996; 35: 779–81.
   PubMed Web of Science ®Google Scholar
• Bonnetblanc JM, BEdane C. Erysipelas: recognition and manage-ment. Am J Clin Dermatol. 2003; 4 (3): 157–63.
   PubMedGoogle Scholar
• Lazzarini L, Conti E, Tositti G, de Lalla F. Erysipelas and cellulitis: clin-ical and microbiological spectrum in an Italian tertiary care hospital. J Infect. 2005; 51 (5): 383–9.
   PubMed Web of Science ®Google Scholar
• Celestin R, Brown J, Kihiczak G, Schwartz RA. Erysipelas: a common potentially dangerous infection. Acta Dermatovenerol Alp Panonica Adriat. 2007; 16 (3): 123–7.
   PubMedGoogle Scholar
• Del Giudice P, Blanc-Amrane V. Bullous erysipelas caused by com-munity-acquired methicillin-resistant Staphylococcus aureus. Dermatology. 2007; 214 (2): 191–2.
   PubMed Web of Science ®Google Scholar
• Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med. 1996; 334 (4): 240–5.
   PubMed Web of Science ®Google Scholar
• Stevens DL. Cellulitis, Pyoderma, Abscesses and other Skin and Sub-cutaneous Infections. In: Cohen J Powederly WG Infectious Diseases 2rd Edition, Mosby Edimburgh 2004.
   Google Scholar
• Baddour LM, Bisno AL. Non-group A beta-hemolytic streptococcal cellulitis. Association with venous and lymphatic compromise. Am J Med. 1985; 79 (2): 155–9.
   PubMed Web of Science ®Google Scholar
• Hughes LL, Styblo TM, Thorns WW, Schwarzmann SW, Landry JC, Heaton D, et al. Cellulitis of the breast as a complication of breast-conserv-ing surgery and irradiation. Am J Clin Oncol. 1997; 20 (4): 338–41.
   PubMed Web of Science ®Google Scholar
• ChmelHamdy M. Recurrent streptococcal cellulitis complicatingradical hysterectomy and radiation therapy. Obstet Gynecol. 1984; 63 (6): 862–4 .
   PubMed Web of Science ®Google Scholar
• Mertz KR, Baddour LM, Bell JL, Gwin JL. Breast cellulitis following breast conservation therapy: a novel complication of medical progress. Clin Infect Dis. 1998; 26 (2): 481–6.
   PubMed Web of Science ®Google Scholar
• Gordon RJ, Lowy FD. Current concepts: bacterial infections in drug users. N Engl J Med. 2005; 353: 1945–54.
   PubMed Web of Science ®Google Scholar
• Gabillot-Carre M, Roujeau JC. Acute bacterial skin infections and cel-lulitis. Curr Opin Infect Dis 2007; 20: 118–23.
   PubMed Web of Science ®Google Scholar
• Sorbello AF. Group A streptococcal resistance to clindamycin and erythromycin. JAMA. 1989; 262 (10): 1329.
   PubMed Web of Science ®Google Scholar
• Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S, et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis. 2000; 31: 705–11.
   PubMed Web of Science ®Google Scholar
• Valeriano-Marcet J, Carter JD, Vasey FB. Soft tissue disease. Rheum Dis Clin North Am. 2003; 29 (1): 77–88.
   PubMed Web of Science ®Google Scholar
• Bodey GP. Unusual presentations of infection in neutropenic patients. Int J Antimicrob Agents. 2000; 16 (2): 93–5.
   PubMed Web of Science ®Google Scholar
• Singh N, Rihs JD, Gayowski T, Yu VL. Cutaneous cryptococcosis mimicking bacterial cellulitis in a liver transplant recipient: case report and re-view in solid organ transplant recipients. Clin Transplant. 1994; 8 (4): 365–8.
   PubMed Web of Science ®Google Scholar
• Anderson DJ, Schmidt C, Goodman J, Pomeroy C. Cryptococcal dis-ease presenting as cellulitis. Clin Infect Dis. 1992; 14 (3): 666–72.
   PubMed Web of Science ®Google Scholar
• Meislin HW. Pathogen identification of abscesses and cellulitis. Ann Emerg Med. 1986; 15 (3): 329–32.
   PubMed Web of Science ®Google Scholar
• Dancer SJ, McNair D, Finn P, Kolsto AB. Bacillus cereus cellulitis from contaminated heroin. J Med Microbiol. 2002; 51 (3): 278–81.
   PubMed Web of Science ®Google Scholar
• Winslow DL, Jones R. Severe cellulitis due to Aeromonas hydrophilia following immersion injury. Del Med J. 1984; 56 (6): 361–2.
   PubMedGoogle Scholar
• Weinstein MR, Litt M, Kertesz DA, Wyper P, Rose D, Coulter M, et al. Invasive infections due to a fish pathogen, Streptococcus iniae. S. iniae Study Group. N Engl J Med. 1997; 337 (9): 589–94.
   PubMed Web of Science ®Google Scholar
• Carter E, Cain K, Rutland B. Chromobacterium violaceum cellulitis and sepsis following cutaneous marine trauma. Cutis. 2008; 81 (3): 269–72.
   PubMed Web of Science ®Google Scholar
• Sebeny PJ, Riddle MS, Petersen K. Acinetobacter baumannii skin and soft-tissue infection associated with war trauma. Clin Infect Dis. 2008; 47 (4): 444–9.
   PubMed Web of Science ®Google Scholar
• Fisher RG, Benjamin DK Jr. Facial cellulitis in childhood: a changing spectrum. South Med J. 2002; 95 (7): 672–4.
   PubMed Web of Science ®Google Scholar
• Giannella M, Pistella E, Perciaccante A, Venditti M. Soft tissue infec-tion caused by Mycobacterium chelonae following a liposculpture and lipofilling procedure. Ann Ital Med Int. 2005; 20: 245–7.
   PubMedGoogle Scholar
• Alfonzo-Perez R, Oliver MO, Escalona A, Guevara A, Pia-Rivera O, de Waard JH, et al. En tejidos blandos por micobacterias no tuberculosas in-fecciones? Cuanto vale la belleza secundarias a mesoterapia. Inferm Infecc Microbiol Clin. 2006; 24; 5: 302–6.
   PubMedGoogle Scholar
• Demidovich CW, Wittier RR, Ruff ME, Bass JW, Browning WC. Im-petigo. Current etiology and comparison of penicillin, erythromycin, and cephalexin therapies. Am J Dis Child. 1990; 144 (12): 1313–5.
   Google Scholar
• Hirschmann JV. Antimicrobial therapy for skin infections. Cutis 2007; 79(6 Suppl): 26–36.
   PubMed Web of Science ®Google Scholar
• Koning S, Verhagen AP, van Suijlekom-Smit LW, Morris A, Butler CC, van der Wouden JC. Interventions for impetigo. Cochrane Database Syst Rev. 2004; (2): CD003261.
   Google Scholar
• Bemard P. Management of common bacterial infections of the skin. Curr Opin Infect Dis. 2008; 21 (2): 122–8.
   PubMed Web of Science ®Google Scholar
• Gould FK, Brindle R, Chadwick PR, Fraise AP, Hill S, Nathwani D, et al. MRSA Working Party of the British Society for Antimicrobial Chemother-apy. Guidelines (2008) for the prophylaxis and treatment of methicillin-re-sistant Staphylococcus aureus (MRSA) infections in the United Kingdom. J Antimicrob Chemother. 2009; 63 (5): 849-61.
   Google Scholar
• Hankin A, Everett WW. Are antibiotics necessary after incision and drainage of a cutaneous abscess? Ann Emerg Med. 2007; 50 (1): 49–51.
   PubMed Web of Science ®Google Scholar
• Lee MC, Rios AM, Aten MF, Mejias A, Cavuoti D, McCracken GH Jr, et al. Management and outcome of children with skin and soft tissue ab-scesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J. 2004; 23 (2): 123-7.
   Google Scholar
• Paydar KZ, Hansen SL, Charlebois ED, Harris HW, Young DM. In-appropriate antibiotic use in soft tissue infections. Arch Surg. 2006; 141 (9): 850–4.
   PubMedGoogle Scholar
• Rajendran PM, Young D, Maurer T, Chambers H, Perdreau-Reming-ton F, Ro P, et al. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus in-fection. Antimicrob Agents Chemother 2007; 51: 4044–8.
   PubMed Web of Science ®Google Scholar
• Ruhe JJ, Smith N, Bradsher RW, Menon A. Community-Onset me-thicillin-resistant Staphylococcus aureus skin and soft-tissue infections: im-pact of antimicrobial therapy on outcome. Clin Infect Dis. 2007; 44 (6): 777–84.
   PubMed Web of Science ®Google Scholar
• Korownyk C, Allan GM. Evidence-based approach to abscess man-agement. Can Fam Physician. 2007; 53 (10): 1680–4.
   PubMedGoogle Scholar
• Moellering RC Jr. Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008; 46 (7): 1032–7.
   PubMed Web of Science ®Google Scholar
• Hyun DY, Mason EO, Forbes A, Kaplan SL. Trimethoprim-sul-famethoxazole or clindamycin for treatment of community-acquired methi-cillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J 2009; 28: 57–9.
   PubMed Web of Science ®Google Scholar
• Cenizal MJ, Skiest D, Luber S, Bedimo R, Davis P, Fox P, et al. Prospective randomized trial of empiric therapy with trimethoprim-sul-famethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2007; 51: 2628–30.
   PubMed Web of Science ®Google Scholar
• Drekonja DM, Traynor LM, DeCarolis DD, Crossley KB, Johnson JR. Treatment of non-life-threatening methicillin-resistant Staphylococcus au-reus infections with alternative antimicrobial agents: a 2-year retrospective review. Diagn Microbiol Infect Dis 2009; 63: 201–7.
   PubMed Web of Science ®Google Scholar
• Ruhe JJ, Menon A. Tetracyclines as an oral treatment option for pa-tients with community onset skin and soft tissue infections caused by methi-cillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2007; 51: 3298–303.
   PubMed Web of Science ®Google Scholar
• Daum RS. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med. 2007; 357 (4): 380–90.
   PubMed Web of Science ®Google Scholar
• Gorwitz, RJ. The role of ancillary antimicrobial therapy for treatment of uncomplicated skin infections in the era of community-associated methi-cillin-resistant Staphylococcus aureus. Clin Infect Dis. 2007; 44 (6): 785–7.
   PubMed Web of Science ®Google Scholar
• El-Gilany Al-I, Fathy H. Risk factors of recurrent furunculosis. Derma-tol Online J. 2009; 15 (1): 16.
   Google Scholar
• Raz R, Miron D, Colodner R, Staler Z, Samara Z, Keness Y. A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection. Arch Intern Med. 1996; 156 (10): 1109–12.
   PubMedGoogle Scholar
• Mashhood AA, Shaikh ZI, Qureshi SM, Malik SM. Efficacy of ri-fampicin in eradication of carrier state of Staphylococcus aureus in anterior nares with recurrent furunculosis. J Coll Physicians Surg Pak 2006; 16: 396–9.
   PubMedGoogle Scholar
• Klempner MS, Styrt B. Prevention of recurrent staphylococcal skin in-fections with low-dose oral clindamycin therapy. JAMA. 1988; 260 (18): 2682–5.
   PubMed Web of Science ®Google Scholar
• Aminzadeh A, Demircay Z, Ocak K, Soyletir G. Prevention of chronic furunculosis with low-dose azithromycin. J Dermatolog Treat 2007; 18: 105–8.
   PubMed Web of Science ®Google Scholar
• Spanish Chemotherapy Society, Spanish Internal Medicine Society, Spanish Association of Surgeons. Treatment guide for skin and soft tissue in-fections. Rev Esp Quimioter. 2006; 19 (4): 378–94.
   PubMedGoogle Scholar
• Nolen T. Comparative studies of cefprozil in the management of skin and soft-tissue infections. Eur J Clin Microbiol Infect Dis. 1994; 13 (10): 866–71.
   PubMed Web of Science ®Google Scholar
• Schatz BS, Karavokiros KT, Taeubel MA, Itokazu GS. Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten. Ann Pharmacother. 1996; 30 (3): 258–68.
   PubMed Web of Science ®Google Scholar
• Wilson SE. The management of skin and skin structure infections in children, adolescents and adults: a review of empiric antimicrobial therapy. Int J Clin Pract. 1998; 52 (6): 414–7.
   PubMed Web of Science ®Google Scholar
• Jacobs MR, Jones RN, Giordano PA. Oral beta-lactams applied to un-complicated infections of skin and skin structures. Diag Microbiol Infect Dis. 2007; 57 (3 Suppl):55S-655.
   Google Scholar
• Parish LC, Routh HB, Miskin B, Fidelholtz J, Werschler P, Heyd A, et al. Moxifloxacin versus cephalexin in the treatment of uncomplicated skin infections. Int J Clin Pract. 2000; 54 (8): 497–503.
   PubMed Web of Science ®Google Scholar
• Nicodemo AC, Robledo JA, Jasovich A, Neto W. A multicentre, dou-ble-blind, randomised study comparing the efficacy and safety of oral lev-ofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections. Int J Clin Pract. 1998; 52 (2): 69–74.
   PubMed Web of Science ®Google Scholar
• Tarshis GA, Miskin BM, Jones TM, Champlin J, Wingert KJ, Breen JD, et al. Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, ran-domized study. Antimicrob Agents Chemother. 2001; 45 (8): 2358–62.
   PubMed Web of Science ®Google Scholar
• Blondeau JM. The role of fluoroquinolones in skin and skin structure infections. Am J Clin Dermatol. 2002; 3 (1): 37–46.
   PubMedGoogle Scholar
• Owens RC Jr, Lamp KC, Friedrich LV, Russo R. Postmarketing clin-ical experience in patients with skin and skin-structure infections treated with daptomycin. Am J Med. 2007; 120 (10 Suppl 1):56-12.
   Google Scholar
• Pertel PE, Eisenstein BI, Link AS, Donfrid B, Biermann EJ, Bernardo P, et al. The efficacy and safety of daptomycin vs. vancomycin for the treat-ment of cellulitis and erysipelas. Int J Clin Pract. 2009; 63 (3): 368–75.
   PubMed Web of Science ®Google Scholar
• Wible K, Tregnaghi M, Bruss J, Fleishaker D, Naberhuis-Stehouwer S, Hilty M. Linezolid versus cefadroxil in the treatment of skin and skin struc-ture infections in children. Pediatr Infect Dis J. 2003; 22 (4): 315–23.
   PubMed Web of Science ®Google Scholar
• Koster JB, Kullberg BJ, Van der Meer JW. Recurrent erysipelas de-spite antibiotic prophylaxis: an analysis from case studies. Neth J Med 2007; 65: 89–94.
   PubMed Web of Science ®Google Scholar
• Leclerc S, Teixeira A, Maht E, Descamps V, Crickx B, Chosidow O. Recurrent erysipelas: 47 cases. Dermatology 2007; 214: 52–7.
   PubMed Web of Science ®Google Scholar
• Vignes S, Dupuy A. Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study. J Eur Acad Dermatol 2006; 20: 818–22.
   Web of Science ®Google Scholar
• Sjoblom AC, Eriksson B, Jorup-Ronstrom C, Karkkonen K, Lindqvist M. Antibiotic prophylaxis in recurrent erysipelas. Infection 1993; 21: 390–3.
   PubMed Web of Science ®Google Scholar
• Gentry LO, Ramirez-Ronda CH, Rodriguez-Noriega E, Thadepalli del Rosal PL, Ramirez C. Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial. Arch Intern Med. 1989; 149 (11): 2579–83.
   Google Scholar
• Muijsers RB, Jarvis B. Moxifloxacin in uncomplicated skin and skin structure infections. Drugs. 2002; 62 (6): 967–73.
   PubMed Web of Science ®Google Scholar
• Langtry HD, Lamb HM. Levofloxacin. Its use in infections of the res-piratory tract, skin, soft tissues and urinary tract. Drugs. 1998; 56 (3): 487–515.
   Google Scholar
• Swartz MN. Cellulitis. N Engl J Med. 2004; 350 (9): 904–12.
   PubMed Web of Science ®Google Scholar
• Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karch-mer AW, et al; Infectious Diseases Society of America. Diagnosis and treat-ment of diabetic foot infections. Clin Infect Dis. 2004; 39 (7): 885–910.
   PubMed Web of Science ®Google Scholar
• Bross MH, Soch K, Morales R, Mitchell RB. Vibrio vulnificus infec-tion: diagnosis and treatment. Am Fam Physician. 2007; 76 (4): 539–44.
   PubMed Web of Science ®Google Scholar
• Oliver JD. Wound infections caused by Vibrio vulnificus and other marine bacteria. Epidemiol Infect. 2005; 133 (3): 383–91.
   PubMed Web of Science ®Google Scholar
• Chuang YC, Ko WC, Wang ST, Liu JW, Kuo CF, Wu JJ, et al. Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection. Antimicrob Agents Chemother 1998; 42 (6): 1319–22.
   PubMed Web of Science ®Google Scholar
• Liu JW, Lee IK, Tang HJ, Ko WC, Lee HC, Liu YC, et al. Prognos-tic factors and antibiotics in Vibrio vulnificus septicemia. Arch Intern Med. 2006; 166 (19): 2117–23.
   PubMedGoogle Scholar
• Tang HJ, Chang MC, Ko WC, Huang KY, Lee CL, Chuang YC. In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnifi-cus. Antimicrob Agents Chemother. 2002; 46 (11): 3580–4.
   PubMed Web of Science ®Google Scholar
• Janda JM, Abbott SL. The genus Aeromonas: taxonomy, patho-genicity, and infection. Clin Microbiol Rev. 2010; 23 (1): 35–73.
   PubMed Web of Science ®Google Scholar
• Venditti M, Gelfusa V, Tarasi A, Brandimarte C, Serra P. Antimicro-bial susceptibilities of Erysipelothrix rhusiopathiae. Antimicrob Agents Chemother. 1990; 34: 2038–40.
   PubMed Web of Science ®Google Scholar
• Venditti M, Gelfusa V, Castelli F, Brandimarte C, Serra P. Erysipelothrix rhusiopathiae endocarditis. Eur J Clin Microbiol Infect Dis. 1990; 9: 50–52.
   PubMed Web of Science ®Google Scholar
• Brooke CJ, Riley TV. Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. J Med Microbiol. 1999; 48 (9): 789–99.
   PubMed Web of Science ®Google Scholar
• Weigelt J, Itani K, Stevens D, Lau W, Dryden M, Knirsch C; Linezolid CSSTI Study Group. Linezolid versus vancomycin in treatment of compli-cated skin and soft tissue infections. Antimicrob Agents Chemother. 2005; 49 (6): 2260–6.
   Google Scholar
• Arbeit RD, Maki D, Tally FP, Campanaro E, Eisenstein BI; Dapto-mycin 98-01 and 99-01 Investigators. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin In-fect Dis. 2004; 38 (12): 1673–81.
   Google Scholar
• Ellis-Grosse EJ, Babinchak T, Dartois N, Rose G, Loh E; Tigecycline 300 cSSSI Study Group; Tigecycline 305 cSSSI Study Group. The efficacy and safety of tigecycline in the treatment of skin and skin-structure infec-tions: results of 2 double-blind phase 3 comparison studies with vancomycin aztreonam. Clin Infect Dis 2005; 41 (Suppl 5):S341-53.
   Google Scholar
• Unal S. Treatment options for skin and soft tissue infections: ëoldies but goldiesi. Int J Antimicrob Agents. 2009; 34 Suppl 1: S20–3.
   PubMedGoogle Scholar
• Kremer M, Zuckerman R, Avraham Z, Raz R. Long-term antimicro-bial therapy in the prevention of recurrent soft-tissue infections. J Infect. 1991; 22 (1): 37–40.
   PubMed Web of Science ®Google Scholar
• Talan DA, Citron DM, Abrahamian FM, Moran GJ, Goldstein EJ. Bacteriologic analysis of infected dog and cat bites. Emergency Medicine An-imal Bite Infection Study Group. N Engl J Med. 1999; 340 (2): 85–92.
   PubMed Web of Science ®Google Scholar
• Weber DJ, Wolfson JS, Swartz MN, Hooper DC. Pasteurella mul-tocida infections. Report of 34 cases and review of the literature. Medicine (Baltimore). 1984; 63 (3): 133-54.
   Google Scholar
• Brenner DJ, Hollis DG, Fanning GR, Weaver RE. Capnocytophaga can imorsus sp. nov. (formerly CDC group DF-2), a cause of septicemia fol-lowing dog bite, and C. cynodegmi sp. nov., a cause of localized wound in-fection following dog bite. J Clin Microbiol. 1989; 27 (2): 231-5.
   Google Scholar
• Goldstein El. New horizons in the bacteriology, antimicrobial sus-ceptibility and therapy of animal bite wounds. J Med Microbiol 1998; 47: 95–7.
   PubMed Web of Science ®Google Scholar
• Peel MM, Hornidge KA, Luppino M, Stacpoole AM, Weaver RE. Actinobacillus spp. and related bacteria in infected wounds of humans bit-ten by horses and sheep. J Clin Microbiol. 1991; 29 (11): 2535–8.
   Google Scholar
• Norton C. Animal and human bites. Emerg Nurse. 2008; 16 ( 6): 26-9. Review.
   Google Scholar
• Talan DA, Abrahamian FM, Moran GJ, Citron DM, Tan JO, Gold-stein EJ. Emergency Medicine Human Bite Infection Study Group. Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments. Clin Infect Dis. 2003; 37 (11): 1481–9.
   Google Scholar
• Vidmar L, Poljak M, Tomazic J, Seme K, Klavs I. Transmission of HIV-1 by human bite. Lancet 1996; 347:1762.
   Google Scholar
• Dusheiko GM, Smith M, Scheuer PJ. Hepatitis C virus transmitted by human bite. Lancet 1990; 336: 503–4.
   PubMed Web of Science ®Google Scholar
• Davis LG, Weber DJ, Lemon SM. Horizontal transmission of hepati-tis B virus. Lancet 1989; 1: 889–93.
   PubMed Web of Science ®Google Scholar
• Reilly J, Allardice G, Bruce J, Hill R, McCoubrey J. Procedure-spe-cific surgical site infection rates and post discharge surveillance in Scotland. Infect Control Hosp Epidemiol. 2006c; 27 (12): 1318–23.
   PubMed Web of Science ®Google Scholar
• Nichols RL. Prevention of infection in high risk gastrointestinal sur-gery. Am J Med 1984; 76: 111–9.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National Nosocomial In-fections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1996; 24: 380–8.
   Google Scholar
• Anderson DJ, Kaye KS. Staphylococcal surgical site infections. Infect Dis Clin North Am. 2009; 23 (1): 53–72.
   PubMed Web of Science ®Google Scholar
• Popovich KJ, Weinstein RA, Hota B. Are community-associated me-thicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis 2008; 46: 787–94.
   Google Scholar
• Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guide-line for prevention of surgical site infection, 1999: Hospital Infection Con-trol Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20: 250–78.
   PubMed Web of Science ®Google Scholar
• Whitney JA, Phillips L, Aslam R, Barbul A, Gottrup F, Gould L, Rob-son MC, et al. Guidelines for the treatment of pressure ulcers. Wound Rep Reg. 2006; 14: 6: 663–79.
   PubMed Web of Science ®Google Scholar
• Garcia AD, Thomas DR. Assessment and management of chronic pressure ulcers in the elderly. Med Clin N Am 2006; 90: 925–44.
   PubMed Web of Science ®Google Scholar
• Bansal C, Scott R, Steward D, Cockerell CJ. Decubitus ulcers: a re-view of the literature. Int J Dermatol 2005; 44: 805–10.
   PubMed Web of Science ®Google Scholar
• Bluelstein D, Javaheri A. Pressure ulcers: prevention, evaluation, and management. Ann Fam Physician 2008; 78: 1186–96.
   PubMed Web of Science ®Google Scholar
• Livesley NJ, Chow AW. Infected pressure ulcers in elderly individuals. Clin Infect Dis 2002; 35: 1390–6.
   PubMed Web of Science ®Google Scholar
• Bates-Jensen BM, MacLean CH. Quality indicators for the care of pressure ulcers in vulnerable elders. J Am Geriatr Soc 2007; 55: S409–16.
   PubMed Web of Science ®Google Scholar
• Davies BJ, Bowler PG. The microbiology of infected and noninfected leg ulcers. Int J Dermatol 1999; 101: 6–38.
   Google Scholar
• Fleisher GR. The management of bite wounds. N Engl J Med 1999; 340: 138–40.
   PubMed Web of Science ®Google Scholar
• Goldstein EJ, Citron DM, Finegold SM. Dog bite wounds and infec-tion: a prospective clinical study. Ann Emerg Med 1980; 9: 508–12.
   PubMed Web of Science ®Google Scholar
• Brook I. Management of human and animal bite wound infection. Curr Infect Dis Rep. 2009; 11 (5): 389–95.
   PubMedGoogle Scholar
• Stefanopoulos PK. Management of facial bite wounds. Oral Maxillo-fac Surg Clin North Am 2009; 21: 247–57.
   PubMed Web of Science ®Google Scholar
• Goldstein El, Reinhardt JF, Murray PM, Finegold SM. Outpatient therapy of bite wounds. Demographic data, bacteriology, and a prospective, randomized trial of amoxicillin/clawlanic acid versus penicillin +/- di-cloxacillin. Int J Dermatol. 1987; 26 (2): 123–7.
   Google Scholar
• Goldstein EJC, Citron DM, Hudspeth M, et al. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in hu-mans. Antimicrobial Agents Chemother 1997; 41: 1552–7.
   PubMed Web of Science ®Google Scholar
• Elenbaas RM, McNabney WK, Robinson WA. Prophylactic oxacillin in dog bite wounds. Ann Emerg Med. 1982; 11 (5): 248–51.
   PubMed Web of Science ®Google Scholar
• Elenbaas RM, McNabney WK, Robinson WA. Evaluation of prophy-lactic oxacillin in cat bite wounds. Ann Emerg Med. 1984; 13 (3): 155–7.
   PubMed Web of Science ®Google Scholar
• Stierman KL, Lloyd KM, De Luca-Pytell DM, Phillips LG, Calhoun KH. Treatment and outcome of human bites in the head and neck. Oto-laryngol Head Neck Surg. 2003; 128 (6): 795–801.
   PubMed Web of Science ®Google Scholar
• Morgan M. Hospital management of animal and human bites. J Hosp Infect. 2005; 61 (1): 1–10.
   PubMed Web of Science ®Google Scholar
• Moran GJ, Talan DA, Abrahamian FM. Antimicrobial prophylaxis for wounds and procedures in the emergency department. Infect Dis Clin North Am 2008; 22: 117–43.
   PubMed Web of Science ®Google Scholar
• Esposito S, Leone S, Petta E, Noviello S, Ianniello F. Treatment options for skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus: oral vs. parenteral; home vs. hospital. Int J An-timicrob Agents. 2009; 34 Suppl 1: S30–5.
   PubMedGoogle Scholar
• Karchmer AW, Bayer AS. Methicillin-resistant Staphylococcus aureus: an evolving clinical challenge. Clin Infect Dis 2008; 46(Suppl 5):S342–3.
   PubMedGoogle Scholar
• Gould IM. The problem with glycopeptides. Int J Antimicrob Agents. 2007; 30 (1): 1–3.
   PubMed Web of Science ®Google Scholar
• Awad S, Elhabash SI, Lee L, Farrow B, Berger DH. Increasing inci-dence of methicillin-resistant Staphylococcus aureus skin and soft tissue in-fections: reconsideration of antimicrobial therapy. Am J Surg 2007; 194: 606–10.
   PubMed Web of Science ®Google Scholar
• Nathwani D. New antibiotics for the management of complicated skin and soft tissue infections: are they any better? Int J Antimicrob Agents. 2009; 34 Suppl 1: S24–9.
   PubMedGoogle Scholar
• itani KM, Dryden Ms, Bhattacharyya H, Kunkel MJ, Baruch AM, Weigelt JA. Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus. Am J Surg. 2010 Jun;199 (6): 804–16.
   PubMedGoogle Scholar
• Bounthavong M, Hsu DI. Efficacy and safety of linezolid in methi-cillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tis-sue infection (cSSTI): a meta-analysis. Curr Med Res Opin. 2010 Feb; 26 (2): 407–21.
   PubMed Web of Science ®Google Scholar
• Stevens DL, Ma Y, Salmi DB, McIndoo E, Wallace RJ, Bryant AE. Im-pact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J In-fect Dis 2007; 195: 202–11.
   Google Scholar
• Davis SL, McKinnon PS, Hall LM, Delgado G Jr, Rose W, Wilson RF, et al. Daptomycin versus vancomycin for complicated skin and soft tis-sue infections: clinical and economic outcomes. Pharmacotherapy 2007; 27: 1611–8.
   PubMed Web of Science ®Google Scholar
• Bliziotis IA, Plessa E, Peppas G, Falagas ME. Daptomycin versus other antimicrobial agents for the treatment of skin and soft tissue infections: a meta-analysis. Ann Pharmacother. 2010 Jan; 44 (1): 97–106
   PubMed Web of Science ®Google Scholar
• Armstrong DG, Athanasiou KA. The edge effect: how and why wounds grow in size and depth. Clin Podiatr Med Surg. 1998; 15 (1): 105–8.
   PubMedGoogle Scholar
• Steed DL, Donohoe D, Webster MW, Lindsley L. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg. 1996; 183 (1): 61–4.
   PubMed Web of Science ®Google Scholar
• Takahashi PY, Kiemele LJ, Jones JP. Wound care for elderly pa-tients: advances and clinical applications for practicing physicians. Mayo Clin Proc 2004; 79: 260–7.
   PubMed Web of Science ®Google Scholar
• Gregor S, Maegele M, Sauerland S, Krahn JF, Peinemann F, Lange S. Negative pressure wound therapy. A vacuum of evidence? Arch Surg 2008; 143: 189–96.
   PubMedGoogle Scholar
• Esposito S, Noviello S, Leone S. Infezioni della cute e dei tessuti molli: opzioni terapeutiche. Infez Med 2008; 16: 65–73.
   PubMedGoogle Scholar
• Small LN, Ross JJ. Tropical and temperate pyomyositis. Infect Dis Clin North Am. 2005; 19 ( 4): 981-9, x-xi.
   Google Scholar
• Crum NF. Bacterial pyomyositis in the United States. Am J Med. 2004; 117 (6): 420–8.
   PubMed Web of Science ®Google Scholar
• Geelhoed GW, Gray H, Alavi IA, Lattoo H. Pyomyositis-tropical and nontropical. N Engl J Med, 1971; 284: 853–4.
   PubMed Web of Science ®Google Scholar
• Christin L, Sarosi GA. Pyomyositis in North America: case reports and review. Clin Infect Dis, 1992; 15: 668–77.
   PubMed Web of Science ®Google Scholar
• Widrow CA, Kellie SM, Saltzman BR, Mathur-Wagh U. Pyomyositis in patients with the human immunodeficiency virus: an unusual form of dis-seminated bacterial infection. Am J Med. 1991; 91: 129–36.
   PubMed Web of Science ®Google Scholar
• Rodgers WB, Yodlowski ML, Mintzer CM. Pyomyositis in patients who have the human immunodeficiency virus. Case report and review of the literature. J Bone Joint Surg Am. 1993; 75A:588–92.
   Web of Science ®Google Scholar
• Bickels J, Ben-Sira L, Kessler A, Wientroub S. Primary pyomyositis. J Bone Joint Surg Am. 2002; 84-A (12): 2277-86.
   Google Scholar
• Brook I. Microbiology and management of soft tissue and muscle in-fections. Int J Surg. 2008; 6 (4): 328–38.
   PubMedGoogle Scholar
• Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 2007; 44: 705–10.
   PubMed Web of Science ®Google Scholar
• Sarani B, Strong M, Pascual J, et al. Necrotizing fasciitis: current con-cepts and review of the literature. J Am Coll Surg. 2009; 208 (2): 279–88.
   PubMed Web of Science ®Google Scholar
• Brook I, Frazier EH. Clinical and microbiological features of necro-tizing fasciitis. J Clin Microbiol. 1995; 33 (9): 2382–7.
   PubMed Web of Science ®Google Scholar
• Lee CH, Wang CC, Yue CT, Li KJ, Wu YK. Necrotising fasciitis caused by Vibrio vulnificus in a man with cirrhosis. Lancet Infect Dis. 2008; 8 (6): 399.
   PubMed Web of Science ®Google Scholar
• Cline KA, Turnbull TL. Clostridial myonecrosis. Ann Emerg Med. 1985; 14 (5): 459–66.
   PubMed Web of Science ®Google Scholar
• Jacob ZC, Dedekian M, Seoudi H. Nontraumatic clostridial my-onecrosis: an indication for colonoscopy? Am Surg. 2002; 68 (5): 463–5.
   PubMed Web of Science ®Google Scholar
• Brewer GE, Meleney FL. Progressive gangrenous infection of the skin and subcutaneous tissues following operation for acute perforative appen-dicitis. a study in symbiosis. Ann Surg. 1926; 84 (3): 438–50.
   PubMedGoogle Scholar
• Stone HH, Martin JD Jr. Synergistic necrotizing cellulitis. Ann Surg. 1972; 175 (5): 702–11.
   PubMed Web of Science ®Google Scholar
• Eke N. Foumieris gangrene: A review of 1726 cases. Br J Surg 2000; 87: 718–28.
   PubMed Web of Science ®Google Scholar
• Basoglu M, Ozbey I, Atamanalp SS, Yildirgan MI, Aydinli B, Polat O, et al. Management of Fournieris gangrene: review of 45 cases. Surg Today. 2007; 37 (7): 558–63.
   PubMed Web of Science ®Google Scholar
• Villanueva-S•enz E, Martinez Hern•ndez-Magro P, ValdEs Ovalle M, Montes Vega J, Alvarez-Tostado F JF. Experience in management of Fournieris gangrene. Tech Coloproctol. 2002 ; 6 (1): 5–10.
   PubMedGoogle Scholar
• Levenson RB, Singh AK, Novelline RA. Fournier gangrene: role of imaging. Radiographics. 2008; 28 (2): 519–28.
   PubMed Web of Science ®Google Scholar
• Smith GL, Bunker CB, Dinneen MD. Fournieris gangrene. Br J Uro1. 1998; 81 (3): 347–55.
   PubMedGoogle Scholar
• Frank G, Mahoney HM, Eppes SC. Musculoskeletal infections in chil-dren. Pediatr Clin North Am. 2005; 52 ( 4): 1083-106, ix.
   Google Scholar
• Pannaraj PS, Hulten KG, Gonzalez BE, Mason EO Jr, Kaplan SL. Infective pyomyositis and myositis in children in the era of community-ac-quired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2006; 43 (8): 953–60.
   PubMed Web of Science ®Google Scholar
• Crum-Cianflone NF. Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev. 2008; 21 (3): 473–94.
   PubMed Web of Science ®Google Scholar
• Edlich RF, Cross CL, Dahlstrom JJ, Long WB 3rd. Modern concepts of the diagnosis and treatment of necrotizing fasciitis. J Emerg Med. 2010; 39 (2): 261-5.
   Google Scholar
• Hasham S, Matteucci P, Stanley PR, Hart NB. Necrotising fasciitis. BMJ. 2005; 330 (7495): 830–3.
   PubMed Web of Science ®Google Scholar
• Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J 1999; 18: 1096–100.
   PubMed Web of Science ®Google Scholar
• Bradsher RW Jr, Snow RM. Ceftriaxone treatment of skin and soft tis-sue infections in a once daily regimen. Am J Med. 1984; 77 (4C):63-7.
   Google Scholar
• Diazgranados C,Bisno A. Clues to early diagnosis of group A strep-tococcal necrotizing fasciitis. Infect Med 2001; 18: 198–206.
   Google Scholar
• Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, OiRourke K, et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis. 1999; 28 (4): 800–7.
   PubMed Web of Science ®Google Scholar
• Lamothe F, DiAmico P, Ghosn P, Tremblay C, Braidy J, Patenaude JV. Clinical usefulness of intravenous human immunoglobulins in invasive group A streptococcal infections: case report and review. Clin Infect Dis. 1995; 21 (6): 1469–70.
   PubMed Web of Science ®Google Scholar
• Alejandria MM, Lansang MA, Dans LF, et al. Intravenous im-munoglobulin for treating sepsis and septic shock. Cochrane Database Syst Rev 2002; 1: CD001090.
   PubMedGoogle Scholar
• Lille ST, Sato TT, Engrav LH, Foy H, Jurkovich GJ. Necrotizing soft tissue infections: obstacles in diagnosis. J Am Coll Surg 1996; 182: 7–11.
   PubMed Web of Science ®Google Scholar
• Riseman JA, Zamboni WA, Curtis A, Graham DR, Konrad HR, Ross DS. Hyberbaric oxygen therapy for necrotising fasciitis reduces mortality and the need for debridements. Surgery 1990; 108: 847–50
   PubMed Web of Science ®Google Scholar